AstraZeneca Pays 660% Premium for Gene Therapy Firm LogicBio - Latest Tweet by Reuters

The latest Tweet by Reuters states, 'AstraZeneca pays 660% premium for gene therapy firm LogicBio ...'

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)

Share Now